The Association of Iodixanol (Visipaque) to Renal Function and Cardiac and Cerebrovascular Events in STEMI Patients Undergoing Primary PCI: A Prospective, Multi-National, Multi-Center, Open-Label, Observational Study
Phase of Trial: Phase IV
Latest Information Update: 03 Dec 2019
Price : $35 *
At a glance
- Drugs Iodixanol (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Sponsors GE Healthcare
- 28 Nov 2019 Planned End Date changed from 1 Sep 2019 to 1 Jun 2020.
- 28 Nov 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Jun 2020.
- 20 Dec 2018 Status changed from not yet recruiting to recruiting.